Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.
Aclaris Therapeutics secures global rights to Biosion’s antibodies
BSI-045B has demonstrated safety and efficacy for moderate to severe atopic dermatitis. Credit: Stock-Asso/Shutterstock. Aclaris Therapeutics has secured an exclusive licence from Biosion for the
November 19, 2024